Press Releases

Year

02 Mar '21

Acutus Medical Receives Vizient Innovative Technology Contract

Contract Pricing Now Widely Available for the AcQMap® High Resolution 3D Imaging and Mapping System CARLSBAD, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB) today announced that it has received an Innovative Technology contract from Vizient, Inc., the largest,

09 Feb '21

Acutus Medical, Inc. Appoints New Chief Financial Officer and New Board Member

David Roman appointed Chief Financial Officer Daniella Cramp to join Board of Directors CARLSBAD, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB) today announced the appointment of David Roman as the company’s Chief Financial Officer, effective March 1, 2021.

04 Feb '21

Acutus Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

CARLSBAD, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the BTIG Virtual MedTech, Digital

28 Jan '21

Acutus Medical Suite of EP Products To Be Featured During Recorded Cases at AF Symposium 2021

Innovative Technologies Improve the Treatment of Persistent AF Patients CARLSBAD, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB) today announced the presentation of two mapping and ablation procedures during the 26 th Annual International AF Symposium

13 Jan '21

Acutus Medical Reports Preliminary, Unaudited Fourth Quarter and Full Year 2020 Results

CARLSBAD, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited revenue results for the quarter and full year ended

28 Dec '20

Acutus Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference

CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that its management will present at the upcoming J.P.

10 Dec '20

Acutus Medical Announces CE Mark and European Launch of AcQCross™ Transseptal System, a Fully Integrated Family of Transseptal Crossing Products

Designed to Improve Safety and Efficiency in Any Procedure Requiring Left Heart Access CARLSBAD, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced CE

07 Dec '20

Acutus Medical Launches AcQBlate® Force Sensing Ablation System in Europe

Gold-Tipped Force Sensing Ablation Catheter Earns CE Mark, Expanding Acutus’ Comprehensive Electrophysiology Portfolio CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed

12 Nov '20

Steven Mickelsen, MD, Joins Acutus Medical as Chief Translational Science Officer

CARLSBAD, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB) today announced the appointment of Steven Mickelsen, MD, as Chief Translational Science Officer. Dr. Mickelsen will help guide the company’s vision to deliver the most advanced electrophysiology therapeutic solutions

12 Nov '20

Acutus Medical Reports Third Quarter 2020 Results

CARLSBAD, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third quarter of 2020.

Pagination

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Page 14
…
Next page
Last page

Displaying 91 - 100 of 145